Features Screener Stocks Charts
Sign In Sign Up

Granules India Limited Cash Flow Statement

NSE:GRANULES | PHARMACEUTICALS

Showing 2 of 10 years of data. Sign up free for 3 years, or upgrade for full access.

View Plans

Cash Flow Insights

Cash Conversion

1.31x

GRANULES's operating cash flow exceeded net income in FY 2025, indicating earnings are backed by actual cash generation.

Free Cash Flow

₹2.95B

GRANULES's free cash flow was ₹2.95B in FY 2025, up 401.2% from FY 2024.

Dividend Coverage

8.1x

GRANULES's free cash flow covered dividends 8.1x in FY 2025, leaving room for reinvestment or debt reduction.

CapEx Intensity

66.0%

Capital expenditure consumed 66.0% of operating cash flow in FY 2025 for GRANULES, typical of capital-intensive industries.

2-year GRANULES cash flow snapshot

Hover the chart icon for YoY change.

FY 2024 - FY 2025
Item Chart 2024 2025
Net Income 5.47B 6.60B
Cash flow Operating Activities 4.39B 8.67B
Investments in PPE -3.81B -5.72B
Cash flow Investing Activities -3.60B -6.91B
Dividend Paid -363.06M -363.55M
Cash flow Financing Activities 76.64M -925.06M
Cash at beginning of period 2.92B 3.81B
Cash at end of period 3.81B 4.66B
Free Cash Flow 588.38M 2.95B

Values are shown in millions (M) and billions (B). All amounts are in Indian Rupees (₹).

Data from audited consolidated filings. For educational purposes only — not investment advice. Last update: Mar-2025